Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QE34
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 11 |
GO:0006694 | steroid biosynthetic process | 5 | 11 |
GO:0006743 | ubiquinone metabolic process | 5 | 2 |
GO:0006744 | ubiquinone biosynthetic process | 6 | 2 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0008202 | steroid metabolic process | 4 | 11 |
GO:0008610 | lipid biosynthetic process | 4 | 11 |
GO:0009058 | biosynthetic process | 2 | 11 |
GO:0009987 | cellular process | 1 | 2 |
GO:0042180 | cellular ketone metabolic process | 3 | 2 |
GO:0042181 | ketone biosynthetic process | 4 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0044249 | cellular biosynthetic process | 3 | 2 |
GO:0044281 | small molecule metabolic process | 2 | 2 |
GO:0044283 | small molecule biosynthetic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:1901004 | ubiquinone-6 metabolic process | 6 | 2 |
GO:1901006 | ubiquinone-6 biosynthetic process | 7 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 11 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 11 |
GO:1901576 | organic substance biosynthetic process | 3 | 11 |
GO:1901661 | quinone metabolic process | 4 | 2 |
GO:1901663 | quinone biosynthetic process | 5 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity | 5 | 11 |
GO:0005488 | binding | 1 | 2 |
GO:0016229 | steroid dehydrogenase activity | 3 | 11 |
GO:0016491 | oxidoreductase activity | 2 | 11 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 3 | 11 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4 | 11 |
GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4 | 11 |
GO:0044877 | protein-containing complex binding | 2 | 2 |
GO:0016853 | isomerase activity | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 130 | 134 | PF00656 | 0.348 |
CLV_NRD_NRD_1 | 35 | 37 | PF00675 | 0.545 |
CLV_NRD_NRD_1 | 361 | 363 | PF00675 | 0.430 |
CLV_NRD_NRD_1 | 392 | 394 | PF00675 | 0.539 |
CLV_NRD_NRD_1 | 80 | 82 | PF00675 | 0.534 |
CLV_PCSK_KEX2_1 | 319 | 321 | PF00082 | 0.506 |
CLV_PCSK_KEX2_1 | 361 | 363 | PF00082 | 0.430 |
CLV_PCSK_KEX2_1 | 79 | 81 | PF00082 | 0.542 |
CLV_PCSK_PC1ET2_1 | 319 | 321 | PF00082 | 0.450 |
CLV_PCSK_PC7_1 | 315 | 321 | PF00082 | 0.496 |
CLV_PCSK_SKI1_1 | 203 | 207 | PF00082 | 0.311 |
CLV_PCSK_SKI1_1 | 335 | 339 | PF00082 | 0.502 |
CLV_PCSK_SKI1_1 | 413 | 417 | PF00082 | 0.447 |
CLV_PCSK_SKI1_1 | 85 | 89 | PF00082 | 0.396 |
CLV_Separin_Metazoa | 102 | 106 | PF03568 | 0.279 |
DEG_APCC_DBOX_1 | 35 | 43 | PF00400 | 0.519 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.676 |
DOC_MAPK_gen_1 | 197 | 206 | PF00069 | 0.279 |
DOC_PP1_RVXF_1 | 201 | 207 | PF00149 | 0.279 |
DOC_PP2B_LxvP_1 | 321 | 324 | PF13499 | 0.435 |
DOC_PP4_FxxP_1 | 21 | 24 | PF00568 | 0.541 |
DOC_SPAK_OSR1_1 | 3 | 7 | PF12202 | 0.572 |
DOC_USP7_MATH_1 | 127 | 131 | PF00917 | 0.259 |
DOC_USP7_MATH_1 | 160 | 164 | PF00917 | 0.418 |
DOC_USP7_MATH_1 | 177 | 181 | PF00917 | 0.279 |
DOC_USP7_MATH_1 | 215 | 219 | PF00917 | 0.362 |
DOC_USP7_UBL2_3 | 138 | 142 | PF12436 | 0.228 |
DOC_WW_Pin1_4 | 375 | 380 | PF00397 | 0.484 |
LIG_14-3-3_CanoR_1 | 117 | 125 | PF00244 | 0.311 |
LIG_14-3-3_CanoR_1 | 284 | 294 | PF00244 | 0.350 |
LIG_14-3-3_CanoR_1 | 3 | 7 | PF00244 | 0.684 |
LIG_14-3-3_CanoR_1 | 361 | 366 | PF00244 | 0.457 |
LIG_14-3-3_CanoR_1 | 368 | 373 | PF00244 | 0.368 |
LIG_AP2alpha_1 | 21 | 25 | PF02296 | 0.615 |
LIG_AP2alpha_2 | 23 | 25 | PF02296 | 0.606 |
LIG_BIR_III_4 | 229 | 233 | PF00653 | 0.384 |
LIG_BRCT_BRCA1_1 | 362 | 366 | PF00533 | 0.473 |
LIG_eIF4E_1 | 62 | 68 | PF01652 | 0.515 |
LIG_FHA_1 | 149 | 155 | PF00498 | 0.311 |
LIG_FHA_1 | 271 | 277 | PF00498 | 0.308 |
LIG_FHA_1 | 336 | 342 | PF00498 | 0.500 |
LIG_FHA_1 | 351 | 357 | PF00498 | 0.333 |
LIG_FHA_1 | 438 | 444 | PF00498 | 0.521 |
LIG_FHA_1 | 63 | 69 | PF00498 | 0.637 |
LIG_FHA_2 | 18 | 24 | PF00498 | 0.678 |
LIG_FHA_2 | 362 | 368 | PF00498 | 0.468 |
LIG_FHA_2 | 379 | 385 | PF00498 | 0.353 |
LIG_LIR_Apic_2 | 20 | 24 | PF02991 | 0.621 |
LIG_LIR_Apic_2 | 338 | 342 | PF02991 | 0.365 |
LIG_LIR_Gen_1 | 217 | 225 | PF02991 | 0.342 |
LIG_LIR_Gen_1 | 363 | 370 | PF02991 | 0.439 |
LIG_LIR_Gen_1 | 371 | 379 | PF02991 | 0.359 |
LIG_LIR_LC3C_4 | 318 | 323 | PF02991 | 0.442 |
LIG_LIR_Nem_3 | 119 | 125 | PF02991 | 0.279 |
LIG_LIR_Nem_3 | 20 | 25 | PF02991 | 0.656 |
LIG_LIR_Nem_3 | 217 | 223 | PF02991 | 0.367 |
LIG_LIR_Nem_3 | 308 | 313 | PF02991 | 0.362 |
LIG_LIR_Nem_3 | 363 | 369 | PF02991 | 0.453 |
LIG_LIR_Nem_3 | 371 | 375 | PF02991 | 0.354 |
LIG_LIR_Nem_3 | 402 | 408 | PF02991 | 0.380 |
LIG_LYPXL_yS_3 | 122 | 125 | PF13949 | 0.279 |
LIG_MYND_1 | 123 | 127 | PF01753 | 0.258 |
LIG_NRBOX | 131 | 137 | PF00104 | 0.279 |
LIG_Pex14_2 | 21 | 25 | PF04695 | 0.615 |
LIG_Pex14_2 | 329 | 333 | PF04695 | 0.429 |
LIG_PTB_Apo_2 | 340 | 347 | PF02174 | 0.375 |
LIG_REV1ctd_RIR_1 | 330 | 339 | PF16727 | 0.406 |
LIG_SH2_CRK | 253 | 257 | PF00017 | 0.384 |
LIG_SH2_GRB2like | 176 | 179 | PF00017 | 0.279 |
LIG_SH2_PTP2 | 259 | 262 | PF00017 | 0.395 |
LIG_SH2_SRC | 259 | 262 | PF00017 | 0.370 |
LIG_SH2_STAT3 | 43 | 46 | PF00017 | 0.591 |
LIG_SH2_STAT3 | 451 | 454 | PF00017 | 0.491 |
LIG_SH2_STAT5 | 220 | 223 | PF00017 | 0.355 |
LIG_SH2_STAT5 | 259 | 262 | PF00017 | 0.382 |
LIG_SH2_STAT5 | 350 | 353 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 377 | 380 | PF00017 | 0.477 |
LIG_SH2_STAT5 | 98 | 101 | PF00017 | 0.279 |
LIG_SH3_3 | 338 | 344 | PF00018 | 0.417 |
LIG_SH3_3 | 467 | 473 | PF00018 | 0.529 |
LIG_SH3_3 | 70 | 76 | PF00018 | 0.577 |
LIG_TRAF2_1 | 397 | 400 | PF00917 | 0.531 |
LIG_TRAF2_2 | 397 | 402 | PF00917 | 0.314 |
LIG_WRC_WIRS_1 | 351 | 356 | PF05994 | 0.468 |
MOD_CK1_1 | 468 | 474 | PF00069 | 0.605 |
MOD_CK1_1 | 5 | 11 | PF00069 | 0.685 |
MOD_CK2_1 | 302 | 308 | PF00069 | 0.360 |
MOD_CK2_1 | 378 | 384 | PF00069 | 0.365 |
MOD_GlcNHglycan | 7 | 10 | PF01048 | 0.607 |
MOD_GlcNHglycan | 95 | 98 | PF01048 | 0.279 |
MOD_GSK3_1 | 117 | 124 | PF00069 | 0.297 |
MOD_GSK3_1 | 7 | 14 | PF00069 | 0.659 |
MOD_N-GLC_1 | 160 | 165 | PF02516 | 0.279 |
MOD_N-GLC_1 | 177 | 182 | PF02516 | 0.279 |
MOD_N-GLC_1 | 190 | 195 | PF02516 | 0.279 |
MOD_N-GLC_1 | 468 | 473 | PF02516 | 0.560 |
MOD_NEK2_1 | 210 | 215 | PF00069 | 0.286 |
MOD_NEK2_1 | 93 | 98 | PF00069 | 0.279 |
MOD_PIKK_1 | 265 | 271 | PF00454 | 0.453 |
MOD_PIKK_1 | 42 | 48 | PF00454 | 0.587 |
MOD_PIKK_1 | 468 | 474 | PF00454 | 0.556 |
MOD_PKA_1 | 361 | 367 | PF00069 | 0.463 |
MOD_PKA_2 | 116 | 122 | PF00069 | 0.311 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.638 |
MOD_PKA_2 | 283 | 289 | PF00069 | 0.330 |
MOD_PKA_2 | 360 | 366 | PF00069 | 0.442 |
MOD_Plk_1 | 190 | 196 | PF00069 | 0.316 |
MOD_Plk_1 | 210 | 216 | PF00069 | 0.150 |
MOD_Plk_1 | 236 | 242 | PF00069 | 0.339 |
MOD_Plk_4 | 121 | 127 | PF00069 | 0.283 |
MOD_Plk_4 | 162 | 168 | PF00069 | 0.283 |
MOD_Plk_4 | 236 | 242 | PF00069 | 0.339 |
MOD_Plk_4 | 270 | 276 | PF00069 | 0.318 |
MOD_Plk_4 | 28 | 34 | PF00069 | 0.584 |
MOD_Plk_4 | 361 | 367 | PF00069 | 0.463 |
MOD_Plk_4 | 62 | 68 | PF00069 | 0.632 |
MOD_Plk_4 | 88 | 94 | PF00069 | 0.336 |
MOD_ProDKin_1 | 375 | 381 | PF00069 | 0.485 |
MOD_SUMO_for_1 | 431 | 434 | PF00179 | 0.474 |
MOD_SUMO_rev_2 | 30 | 39 | PF00179 | 0.537 |
TRG_ENDOCYTIC_2 | 122 | 125 | PF00928 | 0.279 |
TRG_ENDOCYTIC_2 | 220 | 223 | PF00928 | 0.333 |
TRG_ENDOCYTIC_2 | 253 | 256 | PF00928 | 0.416 |
TRG_ENDOCYTIC_2 | 326 | 329 | PF00928 | 0.393 |
TRG_ER_diArg_1 | 223 | 226 | PF00400 | 0.342 |
TRG_ER_diArg_1 | 79 | 81 | PF00400 | 0.542 |
TRG_Pf-PMV_PEXEL_1 | 105 | 109 | PF00026 | 0.357 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDT9 | Leptomonas seymouri | 90% | 100% |
A0A0S4JJB1 | Bodo saltans | 76% | 100% |
A0A1X0P6V3 | Trypanosomatidae | 84% | 100% |
A0A3Q8ICY3 | Leishmania donovani | 98% | 100% |
A4H9B3 | Leishmania braziliensis | 94% | 100% |
A4HXN4 | Leishmania infantum | 98% | 100% |
D0A011 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 86% | 99% |
E9ARE5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
V5B9X0 | Trypanosoma cruzi | 84% | 100% |